Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.5100
+0.0100 (2.00%)
Sep 18, 2026, 10:03 AM EST
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 35.69 million as of September 18, 2026. Its market cap has decreased by -5.68% in one year.
Market Cap
35.69M
Enterprise Value
28.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
ChartMarket Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 35.69M, an increase of 155.75%. That is a compound annual growth rate of 23.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 35.69M | 5.92% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedMira | 45.61M |
| Sona Nanotech | 43.59M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 41.09M |
| Sernova Biotherapeutics | 39.65M |
| Medicenna Therapeutics | 39.23M |
| Telescope Innovations | 37.18M |
| Defence Therapeutics | 37.14M |